The China Policy Accelerator produces actionable policy recommendations on what the United States should do not just abroad but at home, from fixing the defense industrial base to securing critical infrastructure from cyberattack.
Executive Summary U.S. dependence on China for essential medicines is structural—deeper, broader, and more consequential than conventional market analyses suggest. That dependence began with generic medicines and their ingredients but is now growing in biologics manufacturing, first-in-human trials, and synthetic DNA. That dependence is not simply the result of market conditions but rather decades of […]
The House Foreign Affairs South and Central Asia Subcommittee holds a hearing titled, “Export Control Loopholes: Chipmaking Tools and their Subcomponents,” featuring Mr. Chris McGuire as a witness.
Rush Doshi’s testimony to the U.S. Senate Foreign Relations Committee addresses U.S. policy toward Taiwan and steps Congress can take to strengthen deterrence in the Taiwan Strait.
Rush Doshi’s testimony to the U.S. Senate Committee on Banking, Housing, and Urban Affairs addresses the significance of the Defense Production Act and steps Congress can take to reform it.
Productions from the China Strategy Initiative’s China Policy Accelerator
39 results
